KELOWNA, BRITISH COLUMBIA--(MARKET WIRE)--Sep 12, 2007 -- Sernova Corp. (CDNX:SVA.V - News) would like to congratulate Dr. Jannette Dufour and Ms. Katie Halley who have reversed diabetes in an animal model by genetically engineering Sertoli cells to secrete insulin. Sernova owns the exclusive patent rights for the therapeutic use of Sertoli cells to treat diseases including diabetes. These results support the concept that Sertoli cells could be an “implanted drug factory” for numerous disease applications.